# An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

> **NCT05381454** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 80 (actual)

## Conditions studied

- Respiratory Viral Infection
- Antiviral Treatment
- COVID-19

## Interventions

- **DRUG:** Mitoquinone/mitoquinol mesylate

## Key facts

- **NCT ID:** NCT05381454
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-28
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-05-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05381454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05381454, "An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05381454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*